Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Schizophrenia

Free Subscription Articles published in J Clin Psychopharmacol Retrieve available abstracts of 81 articles: HTML format Text format

Single Articles

December 2011
1. REMINGTON G , Kapur S, Foussias G, Agid O, et al
   Tetrabenazine Augmentation in Treatment-Resistant Schizophrenia: A 12-Week, Double-Blind, Placebo-Controlled Trial.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BUCHANAN RW , Panagides J, Zhao J, Phiri P, et al
   Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MIURA I , Takeuchi S, Katsumi A, Mori A, et al
   Effects of Aripiprazole and the Taq1A Polymorphism in the Dopamine D2 Receptor Gene on the Clinical Response and Plasma Monoamine Metabolites Level During the Acute Phase of Schizophrenia.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. JURGENS G , Rasmussen HB, Werge T, Dalhoff K, et al
   Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. TENBACK D , Pijl B, Smeets H, Os JV, et al
   All-Cause Mortality and Medication Risk Factors in Schizophrenia: A Prospective Cohort Study.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. LIN SK , Chen CK, Liu YL
   Aripiprazole and Dehydroaripiprazole Plasma Concentrations and Clinical Responses in Patients With Schizophrenia.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. KUO PH , Kao CF, Chen PY, Chen CH, et al
   Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NEILL E , Rossell SL, McDonald S, Joshua N, et al
   Using Ketamine to Model Semantic Deficits in Schizophrenia.
   J Clin Psychopharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KUMAR D , Muppa M, Kablinger A
   A cytochrome p450 inhibitor in a stable schizophrenic patient: a drug interaction.
   J Clin Psychopharmacol. 2011;31:670-1.
   PubMed     Text format     Related articles   
   
   
   
   
10. ALTAMURA AC , Buoli M, Mauri MC
    Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia: a 4-year follow-up naturalistic study.
    J Clin Psychopharmacol. 2011;31:661-3.
    PubMed     Text format     Related articles   
    
    
    
    
11. HOUENOU J , Homri W, Leboyer M, Drancourt N, et al
    Ibogaine-associated psychosis in schizophrenia: a case report.
    J Clin Psychopharmacol. 2011;31:659.
    PubMed     Text format     Related articles   
    
    
    
    
12. SHIRAYAMA Y , Konishi T, Hashimoto K
    Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trial.
    J Clin Psychopharmacol. 2011;31:659-61.
    PubMed     Text format     Related articles   
    
    
    
    
13. BORBA CP , Fan X, Copeland PM, Paiva A, et al
    Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.
    J Clin Psychopharmacol. 2011;31:653-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SONIK P , Hilty DM, Rossaro L, Bourgeois JA, et al
    Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    J Clin Psychopharmacol. 2011;31:680-2.
    PubMed     Text format     Related articles   
    
    
    
    
15. LETOURNEAU G , Abdel-Baki A, Dubreucq S, Mahone M, et al
    Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
    J Clin Psychopharmacol. 2011;31:671-3.
    PubMed     Text format     Related articles   
    
    
    
    
16. HSU WC , Lin ST, Chen CC, Tsang HY, et al
    A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
    J Clin Psychopharmacol. 2011;31:667-9.
    PubMed     Text format     Related articles   
    
    
    
    
17. TOURIAN L , Margolese HC
    Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
    J Clin Psychopharmacol. 2011;31:665-7.
    PubMed     Text format     Related articles   
    
    
    
    
18. HEMMRICH K , Kappel BA, Paul NE, Goy D, et al
    Antipsychotic drugs increase adipose stem cell differentiation--implications for treatment with antipsychotic drugs.
    J Clin Psychopharmacol. 2011;31:663-5.
    PubMed     Text format     Related articles   
    
    
    
    
19. YASUI-FURUKORI N , Tsuchimine S, Saito M, Nakagami T, et al
    Comparing the influence of dopamine D polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    J Clin Psychopharmacol. 2011;31:633-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
20. SUZUKI Y , Sugai T, Ono S, Sawamura K, et al
    Changes in the Metabolic Parameters and QTc Interval After Switching From Olanzapine to Aripiprazole in Japanese Patients With Stable Schizophrenia.
    J Clin Psychopharmacol. 2011;31:526-8.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
21. JUNG DU , Kelly DL, Oh MK, Kong BG, et al
    Bone Mineral Density and Osteoporosis Risk in Older Patients With Schizophrenia.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ISHITOBI M , Kosaka H, Shukunami K, Murata T, et al
    Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    J Clin Psychopharmacol. 2011;31:400-1.
    PubMed     Text format     Related articles   
    
    
    
    
23. SUZUKI T
    An importance of dose in antipsychotic combination therapy for schizophrenia.
    J Clin Psychopharmacol. 2011;31:399.
    PubMed     Text format     Related articles   
    
    
    
    
24. LIN CH , Lane HY
    Reply to comments by dr suzuki on "a randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia".
    J Clin Psychopharmacol. 2011;31:399-400.
    PubMed     Text format     Related articles   
    
    
    
    
25. NOVICK D
    Reply to Letter on: Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia: 36-Month Results From the European SOHO Study.
    J Clin Psychopharmacol. 2011;31:384-385.
    PubMed     Text format     Related articles   
    
    
    
    
26. MADHUSOODANAN S , Brenner R, Serper MR, Adelsky M, et al
    Use of Paliperidone in Elderly Patients With Schizophrenia and Schizoaffective Disorder: A Prospective Open-Label Short-Term Pilot Study.
    J Clin Psychopharmacol. 2011;31:380-382.
    PubMed     Text format     Related articles   
    
    
    
    
27. WATANABE N , Kasahara M, Sugibayashi R, Nakamura T, et al
    Perinatal use of aripiprazole: a case report.
    J Clin Psychopharmacol. 2011;31:377-9.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
28. LEE AH , Lange C, Ricken R, Hellweg R, et al
    Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KINON BJ , Zhang L, Millen BA, Osuntokun OO, et al
    A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MALIK P , Kemmler G, Hummer M, Riecher-Roessler A, et al
    Sexual Dysfunction in First-Episode Schizophrenia Patients: Results From European First Episode Schizophrenia Trial.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BARBUI C , Accordini S, Nose M, Stroup S, et al
    Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care: A Randomized Controlled Trial.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ISHITOBI M , Kosaka H, Shukunami K, Murata T, et al
    Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia.
    J Clin Psychopharmacol. 2011;31:243-5.
    PubMed     Text format     Related articles   
    
    
    
    
33. QUINTERO J , Barbudo E, Molina JD, Mur C, et al
    The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.
    J Clin Psychopharmacol. 2011;31:240-2.
    PubMed     Text format     Related articles   
    
    
    
    
34. MOUAFFAK F , Kebir O, Picard V, Bonhomme-Faivre L, et al
    Ultra-Resistant Schizophrenia Is Not Associated With the Multidrug-Resistant Transporter 1 (MDR1) Gene rs1045642 Variant.
    J Clin Psychopharmacol. 2011;31:236-238.
    PubMed     Text format     Related articles   
    
    
    
    
35. ANIL YAGCIOGLU AE , Ilhan BC, Goktas MT, Babaoglu MO, et al
    Agranulocytosis related to clozapine in monozygotic twins and association with allelic variants of multidrug resistance gene MDR1.
    J Clin Psychopharmacol. 2011;31:247-9.
    PubMed     Text format     Related articles   
    
    
    
    
36. COSAR B , Taner ME, Eser HY, Altinoz AE, et al
    Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    J Clin Psychopharmacol. 2011;31:169-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. BOONSTRA G , van Haren NE, Schnack HG, Cahn W, et al
    Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients With First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. FERNANDEZ-EGEA E , Miller B, Garcia-Rizo C, Bernardo M, et al
    Metabolic Effects of Olanzapine in Patients With Newly Diagnosed Psychosis.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LINDENMAYER JP , Citrome L, Khan A, Kaushik S, et al
    A Randomized, Double-Blind, Parallel-Group, Fixed-Dose, Clinical Trial of Quetiapine at 600 Versus 1200 mg/d for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. REDDEN L , Rendenbach-Mueller B, Abi-Saab WM, Katz DA, et al
    A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. LAMBERT M , Schimmelmann BG, Schacht A, Suarez D, et al
    Differential 3-Year Effects of First- Versus Second-Generation Antipsychotics on Subjective Well-Being in Schizophrenia Using Marginal Structural Models.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FAN X , Copeland PM, Liu EY, Chiang E, et al
    No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. UCHIDA H , Mamo DC
    Balancing potential risks and benefits of adjunctive use of aripiprazole with risperidone for the treatment of schizophrenia: reply to dr deng et Al.
    J Clin Psychopharmacol. 2011;31:136-7.
    PubMed     Text format     Related articles   
    
    
    
    
44. RIEDEL M , Severus E, Schennach-Wolff R, Musil R, et al
    Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a german clinical-practice evaluation programme.
    J Clin Psychopharmacol. 2011;31:120-2.
    PubMed     Text format     Related articles   
    
    
    
    
45. KELLY DL , Gorelick DA, Conley RR, Boggs DL, et al
    Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
    J Clin Psychopharmacol. 2011;31:86-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. GLICK ID , Stekoll AH, Hays S
    The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia.
    J Clin Psychopharmacol. 2011;31:82-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. RABINOWITZ J , Napryeyenko O, Burba B, Martinez G, et al
    Premorbid functioning and treatment response in recent-onset schizophrenia: prospective study with risperidone long-acting injectable.
    J Clin Psychopharmacol. 2011;31:75-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. KOREKI A , Tsunoda K, Suzuki T, Hirano J, et al
    Clinical and demographic characteristics associated with postural instability in patients with schizophrenia.
    J Clin Psychopharmacol. 2011;31:16-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. COMPTON MT , Kelley ME, Lloyd RB, McClam T, et al
    Predictors of the discharge dosage of an atypical antipsychotic agent among hospitalized, treatment-naive, first-episode psychosis patients in naturalistic, public-sector settings.
    J Clin Psychopharmacol. 2011;31:10-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SKOGH E , Sjodin I, Josefsson M, Dahl ML, et al
    High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug.
    J Clin Psychopharmacol. 2011;31:4-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HU CH , Pai N, Huang XF, Deng C, et al
    Potential control of risperidone-related cognitive deficits by adjunctive aripiprazole treatment.
    J Clin Psychopharmacol. 2011;31:135-6.
    PubMed     Text format     Related articles   
    
    
    
    
52. VAN KOOTEN M , Arends J, Cohen D
    Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.
    J Clin Psychopharmacol. 2011;31:126-8.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
53. MORERA-FUMERO AL , Abreu-Gonzalez P
    Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression.
    J Clin Psychopharmacol. 2010;30:739-41.
    PubMed     Text format     Related articles   
    
    
    
    
54. SANI G , Kotzalidis GD, Simonetti A, Solfanelli A, et al
    Development of Asymptomatic Pancreatitis With Paradoxically High Serum Clozapine Levels in a Patient With Schizophrenia and the CYP1A2*1F/1F Genotype.
    J Clin Psychopharmacol. 2010;30:737-9.
    PubMed     Text format     Related articles   
    
    
    
    
55. HIGUCHI Y , Sumiyoshi T, Kawasaki Y, Ito T, et al
    Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report.
    J Clin Psychopharmacol. 2010;30:732-4.
    PubMed     Text format     Related articles   
    
    
    
    
56. RETTENBACHER MA , Hofer A, Ebenbichler C, Baumgartner S, et al
    Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment.
    J Clin Psychopharmacol. 2010;30:711-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. HAHN MK , Remington G, Bois D, Cohn T, et al
    Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
    J Clin Psychopharmacol. 2010;30:706-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. GHALEIHA A , Noorbala AA, Farnaghi F, Hajiazim M, et al
    A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.
    J Clin Psychopharmacol. 2010;30:678-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. HOFFMANN VP , Case M, Stauffer VL, Jacobson JG, et al
    Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, cont
    J Clin Psychopharmacol. 2010;30:656-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. RISSELADA AJ , Vehof J, Bruggeman R, Wilffert B, et al
    Association between the 1291-C/G polymorphism in the adrenergic alpha-2a receptor and the metabolic syndrome.
    J Clin Psychopharmacol. 2010;30:667-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PEREZ-IGLESIAS R , Mata I, Amado JA, Berja A, et al
    Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.
    J Clin Psychopharmacol. 2010;30:661-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SCHENNACH-WOLFF R , Obermeier M, Seemuller F, Jager M, et al
    Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
    J Clin Psychopharmacol. 2010;30:726-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ANGELOPOULOS EK , Corcondilas M, Kollias CT, Kioulos KT, et al
    A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
    J Clin Psychopharmacol. 2010;30:745-6.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
64. 
    A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial: erratum.
    J Clin Psychopharmacol. 2010;30:652.
    PubMed     Text format     Related articles   
    
    
    
    
65. BASOGLU C , Oner O, Ates AM, Algul A, et al
    Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis.
    J Clin Psychopharmacol. 2010;30:636-8.
    PubMed     Text format     Related articles   
    
    
    
    
66. GHASSABIAN S , Chetty M, Tattam BN, Glen J, et al
    The Participation of Cytochrome P450 3A4 in Clozapine Biotransformation Is Detected in People With Schizophrenia by High-Throughput In Vivo Phenotyping.
    J Clin Psychopharmacol. 2010;30:629-31.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
67. YASUI-FURUKORI N , Furukori H, Sugawara N, Fujii A, et al
    Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. LOFFLER S , Klimke A, Kronenwett R, Kobbe G, et al
    Clozapine Mobilizes CD34+ Hematopoietic Stem and Progenitor Cells and Increases Plasma Concentration of Interleukin 6 in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. LAMBERT M , Conus P, Cotton S, Robinson J, et al
    Prevalence, Predictors, and Consequences of Long-Term Refusal of Antipsychotic Treatment in First-Episode Psychosis.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SUZUKI T , Takeuchi H, Nakajima S, Nomura K, et al
    Magnitude of Rater Differences in Assessment Scales for Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. DULUDE L , Labelle A, Knott VJ
    Acute Nicotine Alteration of Sensory Memory Impairment in Smokers With Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. NOVICK D , Haro JM, Bertsch J, Haddad PM, et al
    Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia: Thirty-Six-Month Results From the European Schizophrenia Outpatient Health Outcomes Study.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. GAFOOR R , Landau S, Craig TK, Elanjithara T, et al
    Esquire Trial: Efficacy and Adverse Effects of Quetiapine Versus Risperidone in First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. NIKISCH G , Baumann P, Wiedemann G, Kiessling B, et al
    Quetiapine and Norquetiapine in Plasma and Cerebrospinal Fluid of Schizophrenic Patients Treated With Quetiapine: Correlations to Clinical Outcome and HVA, 5-HIAA, and MHPG in CSF.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LIN CH , Kuo CC, Chou LS, Chen YH, et al
    A Randomized, Double-Blind Comparison of Risperidone Versus Low-Dose Risperidone Plus Low-Dose Haloperidol in Treating Schizophrenia.
    J Clin Psychopharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
76. DENG C , Chen J, Hu C, Huang XF, et al
    What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?
    J Clin Psychopharmacol. 2010;30:480-1.
    PubMed     Text format     Related articles   
    
    
    
    
77. RABINOWITZ J , Levine S, Martinez G
    Concordance between measures of functioning, symptoms, and change: examining the GAF, CGI-S, CGI-C, and PANSS.
    J Clin Psychopharmacol. 2010;30:478-80.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
78. WINSBERG B , Yeager C, Hobbs B, Wei R, et al
    Metformin provides weight reduction for hospitalized patients receiving polypharmacy.
    J Clin Psychopharmacol. 2010;30:345-6.
    PubMed     Text format     Related articles   
    
    
    
    April 2010
79. LUTZ UC , Hiemke C, Wiatr G, Farger G, et al
    Aripiprazole in pregnancy and lactation: a case report.
    J Clin Psychopharmacol. 2010;30:204-5.
    PubMed     Text format     Related articles   
    
    
    
    
80. HSIEH CH , Liou YJ
    Manic symptoms induced by paliperidone.
    J Clin Psychopharmacol. 2010;30:202-4.
    PubMed     Text format     Related articles   
    
    
    
    
81. JONSDOTTIR H , Opjordsmoen S, Birkenaes AB, Engh JA, et al
    Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level.
    J Clin Psychopharmacol. 2010;30:169-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: